Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.
Sec. Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1473637
This article is part of the Research Topic Autoimmunity: novel insights and future perspectives View all 26 articles

Binding to the Neonatal Fc receptor enhances the pathogenicity of anti-desmoglein-3 antibodies in keratinocytes

Provisionally accepted
Anna Zakrzewicz Anna Zakrzewicz 1Katrien Vanderheyden Katrien Vanderheyden 2Yad Galaly Yad Galaly 1Simon Feldhoff Simon Feldhoff 1Magdalena Sips Magdalena Sips 2Maximilian Brinkhaus Maximilian Brinkhaus 2Ritva Tikkanen Ritva Tikkanen 1*
  • 1 Faculty of Medicine, Institute of Biochemistry, University of Giessen, Giessen, Germany
  • 2 argenx, Industriepark Zwijnaarde 7, Ghent, Belgium

The final, formatted version of the article will be published soon.

    The neonatal Fc receptor (FcRn) is important for numerous cellular processes that involve antibody recycling and trafficking. A major function of FcRn is IgG recycling and half-life prolongation, and FcRn blockade results in a reduction of autoantibodies in IgG-mediated autoimmune diseases. In epithelial cells, FcRn functions in processes different from IgG recycling, such as antibody transcytosis in intestinal cells. In pemphigus vulgaris, an autoimmune disease of the epidermis, IgG autoantibodies directed against desmosomal adhesion proteins, especially desmoglein-3 and -1, cause loss of keratinocyte adhesion. We have previously demonstrated that FcRn blockade with efgartigimod, a human Fc fragment with enhanced FcRn binding, significantly reduces the keratinocyte monolayer fragmentation caused by anti-desmoglein-3 antibodies. This points to a direct function of FcRn in keratinocytes, beyond IgG recycling, but the mechanisms have not yet been elucidated in detail. Here, we show that FcRn binding is required for the full pathogenicity of recombinant anti-desmoglein-3 antibodies in keratinocytes, and that antibodies that exhibit enhanced or reduced FcRn affinity due to targeted substitutions in their Fc region, as well as F(ab')2 fragments not binding to FcRn display different degrees of pathogenicity. Blockade of FcRn by efgartigimod only shows a protective effect on keratinocyte adhesion against antibodies capable of binding to FcRn. Furthermore, antibody-induced degradation of desmoglein-3 in keratinocytes does not depend on FcRn, demonstrating that desmoglein-3 degradation and acantholysis are functionally disconnected processes. Our data suggest that the role of FcRn in autoimmune diseases is likely to be versatile and cell-type dependent, thus stressing the importance of further studies on FcRn function in autoimmune diseases.

    Keywords: Autoimmune Diseases, Autoantibodies, Bullous skin diseases, Pemphigus, neonatal Fc receptor, Fc fragment, Desmoglein 3

    Received: 31 Jul 2024; Accepted: 26 Sep 2024.

    Copyright: © 2024 Zakrzewicz, Vanderheyden, Galaly, Feldhoff, Sips, Brinkhaus and Tikkanen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Ritva Tikkanen, Faculty of Medicine, Institute of Biochemistry, University of Giessen, Giessen, D-35392, Germany

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.